BackWhitehawk Therapeutics Overview

Whitehawk Therapeutics Current Cash

Whitehawk Therapeutics's current cash is $69M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$68.97M
↑ 81.84% YoYΔ $31.04M vs prior year quarter

Peer trimmed avg / median

Loading

Whitehawk Therapeutics Current Cash History

Loading

Whitehawk Therapeutics vs. peers: Current Cash Comparison

Loading

Whitehawk Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Whitehawk Therapeutics (WHWK) FAQ

Whitehawk Therapeutics (WHWK) currently reports a current cash of $69M as of September 2026. That compares with $38M in the prior-year period — up 81.8% year over year. Use the charts on this page to explore Whitehawk Therapeutics's current cash history and peer comparisons.

Whitehawk Therapeutics's current cash increased from $38M to $69M — a 81.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Whitehawk Therapeutics reported $69M in current cash as of September 2026. That compares with $38M in the prior-year period — up 81.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $69M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Whitehawk Therapeutics, and consider following WHWK for alerts when major investors trade the stock.

Whitehawk Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $69M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing WHWK with unrelated industries.

Questions & Answers